Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
172M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
92.9M
-
Shares change
-
-1.79M
-
Total reported value, excl. options
-
$93.4M
-
Value change
-
-$5.27M
-
Number of buys
-
45
-
Number of sells
-
-27
-
Price
-
$1.00
Significant Holders of Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) as of Q2 2024
91 filings reported holding CMPX - Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2024.
Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.9M shares
of 172M outstanding shares and own 54.13% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (22.4M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (11.1M shares), Blackstone Inc. (7.69M shares), BlackRock Inc. (6.61M shares), Rock Springs Capital Management LP (5.51M shares), JANUS HENDERSON GROUP PLC (5.22M shares), MPM BIOIMPACT LLC (5.01M shares), VANGUARD GROUP INC (4.19M shares), FMR LLC (4.13M shares), and Vivo Capital, LLC (3.56M shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.